Correspondence 0001554855-26-001094 from TRINITY BIOTECH PLC (TRIB)
TRINITY BIOTECH PLC
Date: May 20, 2026 · CIK: 0000888721 · Accession: 0001554855-26-001094
AI Filing Summary & Sentiment
Reasoning
Letter
TRINITY BIOTECH PLC May 20, 2026 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, NE Washington, D.C. 20549 Attention: Doris Stacey Gama Re: Trinity Biotech plc Registration Statement on Form F-1 File No. 333- 295842 To Ms. Gama: The undersigned, on behalf of Trinity Biotech plc (“Trinity”), issuer of the securities covered by the above-referenced Registration Statement, hereby respectfully requests that the above-referenced Registration Statement be declared effective by the Securities and Exchange Commission at 4:00 p.m. Eastern Time on Friday, May 22, 2026, or as soon thereafter as possible. Please contact Mary Brown (212-238-8765, mbrown@clm.com) of Carter Ledyard & Milburn LLP with any questions you may have concerning this request. Very truly yours, /s/ John Gillard John Gillard Chief Executive Officer
Show Raw Text
CORRESP
1
filename1.htm
TRINITY BIOTECH PLC May 20, 2026 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street, NE Washington, D.C. 20549 Attention: Doris Stacey Gama Re: Trinity Biotech plc Registration Statement on Form F-1 File No. 333- 295842 To Ms. Gama: The undersigned, on behalf of Trinity Biotech plc (“Trinity”), issuer of the securities covered by the above-referenced Registration Statement, hereby respectfully requests that the above-referenced Registration Statement be declared effective by the Securities and Exchange Commission at 4:00 p.m. Eastern Time on Friday, May 22, 2026, or as soon thereafter as possible. Please contact Mary Brown (212-238-8765, mbrown@clm.com) of Carter Ledyard & Milburn LLP with any questions you may have concerning this request. Very truly yours, /s/ John Gillard John Gillard Chief Executive Officer